ALB and hepatocellular carcinoma: Some new proposed scores, such as ALBi (albumin–bilirubin), PALBi (platelet–albumin–bilirubin), or CAGIB (diabetes, hepatocellular carcinoma, albumin, bilirubin, and creatinine), have also been proposed in some studies [13,57,62,63,64,65,66,67,68,69,70]; in our study, ALBi, but not PALBi, demonstrated good prognostic value, close to the MELD variants.